Skip to main content
TipRanks
Go Ultimate75% OFF

Shahzad Malik Insider Profile

4 Followers

Shahzad Malik, Director at Acutus Medical, holds 1.62M shares in Acutus Medical (Ticker: AFIB), holds 1.70M shares in Axonics Modulation Technologies (Ticker: ~AXNX), holds 1.65M shares in Aravive (Ticker: ARAV).

Shahzad Malik's Trading History

AFIB
Acutus Medical
Jun 22, 2021DirectorUninformative Buy――
~AXNX
Axonics Modulation Technologies
Dec 10, 2018―Uninformative Buy―$120.44M
ARAV
Aravive
Dec 22, 2017―Uninformative Buy―$65.82K
AGEN
Agenus
May 27, 2015DirectorUninformative Buy10.00M$9.98M
HSTOQ
Histogen
Aug 01, 2013―Uninformative Buy211.45K$23.84K
EBS
Emergent Biosolutions
―Director―$0.00
ITRMF
Iterum Therapeutics
―Director――

You May Also Like

Shahzad Malik insider profile FAQ

What is the percentage of profitable transactions made by Shahzad Malik?
The percentage of profitable transactions made by Shahzad Malik is 60%.
What is the average return per transaction made by Shahzad Malik?
The average return per transaction made by Shahzad Malik is 32.20%.
What stocks does Shahzad Malik hold?
Shahzad Malik holds: AFIB, ARAV, ITRMF, ~AXNX, AGEN, HSTOQ, EBS stocks.
What was Shahzad Malik's most profitable transaction?
Shahzad Malik’s most profitable transaction was an Informative Sell of ARAV stock on March 17, 2017. The return on the trade was 90.50%.
What is Shahzad Malik's role in Acutus Medical?
Shahzad Malik's role in Acutus Medical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.